This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/27/15 - 2:02:14 PM ET (BATS BZX Real-time Price)
Div Yield: --
NURO Day's Range
NURO 52 Week Range
NURO Business Summary
NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease and spinal stenosis, and diabetes.View NURO key stats
NeuroMetrix Inc - NURO - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates NeuroMetrix Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate NEUROMETRIX INC (NURO) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and generally disappointing historical performance in the stock itself.